Use of proteolytic enzymes for the manufacture of a medicament for treatment of autoimmun - diseases, in the development of proteins with a c φ h φ 2 - domain are involved

摘要

Diseases the origin of which involves proteins (A) contg. at least one CH2 domain are treated with a compsn. contg. at least one proteolytic enzyme (I). More specifically (I) is papain and/or trypsin, and (A) is a member of the immunoglobulin superfamily, esp. an immunoglobulin.